1997
DOI: 10.1136/jcp.50.12.975
|View full text |Cite
|
Sign up to set email alerts
|

Neurological paraneoplastic syndromes.

Abstract: (y Clin Pathol 1997;50:975-980)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
20
0

Year Published

1999
1999
2012
2012

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 24 publications
(20 citation statements)
references
References 20 publications
0
20
0
Order By: Relevance
“…13 Immunomodulating therapies, such as plasma exchange and intravenous immunoglobulin, may also be beneficial. 12 This patient's case remains an anomaly. The relationship between her exposure to 3 days of corticosteroid treatment and the precipitation of mania with psychosis makes it appear that she suffered from a corticosteroidinduced psychiatric disturbance.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…13 Immunomodulating therapies, such as plasma exchange and intravenous immunoglobulin, may also be beneficial. 12 This patient's case remains an anomaly. The relationship between her exposure to 3 days of corticosteroid treatment and the precipitation of mania with psychosis makes it appear that she suffered from a corticosteroidinduced psychiatric disturbance.…”
Section: Discussionmentioning
confidence: 99%
“…Fifty percent of cases precede the cancer diagnosis. 12 Paraneoplastic limbic encephalitis (PLE), a non-metastatic condition with an autoimmune basis, is a rare disorder characterized by personality changes; depression; seizures; memory loss; dementia; and, less frequently, mania. 13 Some types of cancer are more commonly associated with PLE, such as lung, testis, and breast.…”
Section: Discussionmentioning
confidence: 99%
“…Cdr1 encodes the 34 kDa protein while Cdr2 encodes the CDR62 protein that specifically binds to c-Myc thereby downregulating its activity. Disruption of this interaction by anti-Yo antibodies may increase c-Myc activity, leading to apoptosis of Purkinje cells (Dalmau & Rosenfield, 2008;Nath & Grant, 1997;Voltz, 2002).…”
Section: Antigenmentioning
confidence: 99%
“…Tumour associations 80%-93% of patients with anti-Hu antibodies will have SCLC (Gozzard & Maddison, 2010); Nath & Grant, 1997). Extrathoracic tumours in association with anti-Hu antibodies include neuroblastoma (50%) and prostate cancer (Titulaer et al, 2011).…”
Section: Clinical Associationsmentioning
confidence: 99%
See 1 more Smart Citation